U.K. plan to require drugmakers to pay higher rebates draws criticism from industry group To shore up NHS, rebates would rise from 15.5% to 32.2% of brand-name drug sales in the second half of the year

https://www.statnews.com/pharmalot/2025/03/15/uk-medicines-pharma-rebates-innovation/